ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Alturas Minerals Corp

Alturas Minerals Corp (ALT)

0,01
0,00
( 0,00% )
Aktualisiert: 18:06:46

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,01
Gebot
0,005
Fragen
0,01
Volumen
16.270
0,005 Tagesbereich 0,01
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,01
Handelsbeginn
0,005
Letzte Trade
200
@
0.005
Letzter Handelszeitpunkt
18:51:37
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
145.632.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,03
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-487k

Über Alturas Minerals Corp

Sektor
Miscellaneous Metal Ores,nec
Branche
Mining & Extracting Div'e
Hauptsitz
Toronto, Ontario, Can
Gegründet
1996
Alturas Minerals Corp is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker ALT. The last closing price for Alturas Minerals was $0,01. Over the last year, Alturas Minerals shares have traded in a share price range of $ 0,00 to $ 0,00.

Alturas Minerals currently has 145.632.000 shares in issue. The market capitalisation of Alturas Minerals is $1,46 million. Alturas Minerals has a price to earnings ratio (PE ratio) of -3.03.

ALT Neueste Nachrichten

/C O R R E C T I O N -- Alteon, Inc./

In the news release, Alteon Signs Agreements for Sale of Approximately $1.4 Million in Common Stock PIPE Transaction, issued earlier today by Alteon, Inc. over PR Newswire, we are advised by the...

Alteon Updates Investors on Alagebrium Development Status

Alteon Updates Investors on Alagebrium Development Status - Alagebrium Preclinical Toxicity Tests Progressing; Company Intends to Perform SPECTRA Clinical Trial Interim Analysis - PARSIPPANY...

Alteon Announces Year-End and Fourth Quarter Results

Alteon Announces Year-End and Fourth Quarter Results PARSIPPANY, N.J., March 15 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced today a net loss of $13,958,646 for the year ended...

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction - 'EMERALD' Trial to Test the Efficacy of Alagebrium in Diabetic Men Who Achieve Limited Benefit from Current Therapies...

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004 PARSIPPANY, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced today...

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diab

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diabetes PARSIPPANY, N.J., Sept. 20 /PRNewswire-FirstCall/ -- Alteon...

Alteon to Change Principal Accountants

Alteon to Change Principal Accountants PARSIPPANY, N.J., Aug. 13 /PRNewswire-FirstCall/ -- Alteon Inc. today announced that KPMG LLP ("KPMG") has informed the company that it has resigned as...

Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D.

Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D. PARSIPPANY, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Alteon Inc. today announced the resignation of Robert C...

Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis

Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis - Preclinical Study in 'Diabetes' Also Identifies Important Role of Sugar in Atherosclerosis - PARSIPPANY, N.J., June...

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypert

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypertension Meeting PARSIPPANY, N.J., April 27 /PRNewswire-FirstCall/...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SCOTScottie Resources Corp
$ 0,99
(500,00%)
1,18k
MMNMonarca Minerals Inc
$ 0,01
(100,00%)
3k
SCLTSearchlight Resources Inc
$ 0,01
(100,00%)
3,4M
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
1,5k
RYORio Silver Inc
$ 0,025
(66,67%)
19,54k
MAHMarksmen Energy Inc
$ 0,005
(-50,00%)
1,85M
VPIVitality Products Inc
$ 0,015
(-40,00%)
30k
GKOGeekco Technologies Corporation
$ 0,03
(-40,00%)
100k
VLXVelox Energy Materials Inc
$ 0,08
(-33,33%)
520
ALYAnalytixInsight Inc
$ 0,01
(-33,33%)
25k
SCLTSearchlight Resources Inc
$ 0,01
(100,00%)
3,4M
ALALX Resources Corp
$ 0,03
(20,00%)
2,9M
QNCQuantum Emotion Corp
$ 0,195
(8,33%)
2,34M
FUUF3 Uranium Corp
$ 0,265
(12,77%)
2,15M
MATEBlockmate Ventures Inc
$ 0,13
(18,18%)
1,98M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen